Frédérik Damm

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

Erdogan Taskesen, Lars Bullinger, Andrea Corbacioglu et al. · Blood · 2010 · 385 citations · Full text

Incidence and Prognostic Influence of <i>DNMT3A</i> Mutations in Acute Myeloid Leukemia

Felicitas Thol, Frédérik Damm, Andrea Lüdeking et al. · Journal of Clinical Oncology · 2011 · 375 citations · Full text

Prognostic Significance of<i>ASXL1</i>Mutations in Patients With Myelodysplastic Syndromes

Felicitas Thol, Inna Friesen, Frédérik Damm et al. · Journal of Clinical Oncology · 2011 · 274 citations · Full text

Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients

Frédérik Damm, Elena Mylonas, Adrien Cosson et al. · Cancer Discovery · 2014 · 243 citations

Impact of <i>IDH1</i> R132 Mutations and an <i>IDH1</i> Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor

Katharina Wagner, Frédérik Damm, Gudrun Göhring et al. · Journal of Clinical Oncology · 2010 · 240 citations